Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Real-Time Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
08037 CH BIOTECH SER
RTNominal unchange1.300 0.000 (0.000%)
Others

18/07/2019 15:45

Ch Biotech Ser (08037) unit signs cooperation agreement

[ET Net News Agency, 18 July 2019] China Biotech Services Holdings Limited (08037) said
its subsidiary Shanghai Longyao Biotech Company Limited (Shanghai Longyao) has entered
into a strategic cooperation agreement with GE Medical Systems Trade and Development
(Shanghai) Co. Ltd.
The parties will jointly develop customised, modularised and closed-system automatic
production process for autologous and allogenic cell therapeutics. As a biotech company
mainly focuses on the chimeric antigen receptor T (CAR-T) cell therapeutics, this
cooperation will help Shanghai Longyao to accelerate the process from research and
development to industrialisation.
The strategic cooperation agreement is valid for three years. (RC)

Remark: Real time quote last updated: 16/12/2019 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2019 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.